🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/04/2012 | 36,68 | 36,83 | 36,62 | 36,64 | -0,29% | 0,57% | 8.033.339 |
| 17/04/2012 | 36,36 | 36,77 | 36,25 | 36,75 | +1,48% | 1,44% | 11.738.019 |
| 16/04/2012 | 36,15 | 36,32 | 36,15 | 36,21 | +0,45% | 0,48% | 14.607.129 |
| 13/04/2012 | 36,35 | 36,36 | 36,04 | 36,05 | -1,28% | 0,87% | 21.859.289 |
| 12/04/2012 | 36,94 | 36,94 | 36,44 | 36,52 | -0,55% | 1,34% | 13.421.107 |
| 11/04/2012 | 36,84 | 36,93 | 36,64 | 36,72 | +0,08% | 0,78% | 11.224.709 |
| 10/04/2012 | 36,94 | 37,11 | 36,69 | 36,69 | -0,72% | 1,14% | 14.655.337 |
| 09/04/2012 | 36,81 | 37,19 | 36,79 | 36,96 | -0,39% | 1,09% | 12.287.066 |
| 05/04/2012 | 36,98 | 37,13 | 36,82 | 37,10 | -0,05% | 0,83% | 14.547.078 |
| 04/04/2012 | 36,83 | 37,17 | 36,74 | 37,12 | +0,46% | 1,17% | 15.940.918 |
| 03/04/2012 | 36,78 | 36,95 | 36,70 | 36,95 | +0,55% | 0,67% | 11.473.609 |
| 02/04/2012 | 36,55 | 36,79 | 36,46 | 36,75 | +0,29% | 0,91% | 11.990.063 |
| 30/03/2012 | 36,39 | 36,66 | 36,31 | 36,64 | +1,03% | 0,97% | 14.794.302 |
| 29/03/2012 | 36,42 | 36,55 | 36,05 | 36,27 | -0,78% | 1,36% | 18.432.434 |
| 28/03/2012 | 36,86 | 37,15 | 36,48 | 36,56 | -1,26% | 1,81% | 17.066.470 |
| 27/03/2012 | 36,98 | 37,21 | 36,91 | 37,02 | +0,36% | 0,83% | 13.298.596 |
| 26/03/2012 | 36,51 | 36,93 | 36,40 | 36,89 | +1,71% | 1,44% | 12.576.734 |
| 23/03/2012 | 35,97 | 36,31 | 35,89 | 36,27 | +1,09% | 1,17% | 11.283.292 |
| 22/03/2012 | 35,82 | 36,19 | 35,81 | 35,88 | -0,27% | 1,07% | 13.615.092 |
| 21/03/2012 | 36,15 | 36,15 | 35,91 | 35,97 | -0,16% | 0,66% | 12.048.856 |
| 20/03/2012 | 35,93 | 36,18 | 35,90 | 36,03 | -0,34% | 0,80% | 14.515.848 |
| 19/03/2012 | 36,20 | 36,30 | 36,11 | 36,15 | -0,37% | 0,53% | 10.215.275 |
| 16/03/2012 | 36,42 | 36,57 | 36,23 | 36,29 | -0,08% | 0,94% | 19.446.164 |
| 15/03/2012 | 36,40 | 36,50 | 36,21 | 36,32 | -0,42% | 0,79% | 12.833.808 |
| 14/03/2012 | 36,63 | 36,64 | 36,35 | 36,47 | -0,16% | 0,81% | 12.322.384 |
| 13/03/2012 | 36,14 | 36,55 | 35,97 | 36,53 | +0,47% | 1,58% | 15.722.725 |
| 12/03/2012 | 35,99 | 36,36 | 35,93 | 36,36 | +1,33% | 1,22% | 11.395.323 |
| 09/03/2012 | 35,76 | 36,16 | 35,74 | 35,88 | +0,53% | 1,17% | 46.658.008 |
| 08/03/2012 | 35,90 | 36,08 | 35,64 | 35,69 | +0,24% | 1,22% | 42.886.256 |
| 07/03/2012 | 35,62 | 35,72 | 35,22 | 35,60 | -0,35% | 1,39% | 17.679.760 |